You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Previously treated Chronic Lymphocytic Leukemia (CLL)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Orelabrutinib in the Treatment of CLL/SLL

Not yet recruiting
  • CLL/SLL
    • (no location specified)
    Jul 26, 2023

    Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

    Completed
    • Lymphoid Leukemia
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Jan 30, 2023

    Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

    Active, not recruiting
    • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 20, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +5 more
    • (no location specified)
    Jul 21, 2023

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Chronic Lymphocytic Leukemia Trial in Boston (IPI-145, Fludarabine, Cyclophosphamide)

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Boston, Massachusetts
    • +1 more
    Mar 10, 2022

    Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Granada, Spain
      • +4 more
      Nov 8, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • TQB3909 tablet
      • Zhengzhou, Henan, China
      • +1 more
      Jul 17, 2023

      Chronic Lymphocytic Leukemia Trial in Cologne (Ibrutinib, Placebo)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Cologne, Germany
        German CLL Study Group
      Dec 16, 2021

      Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

      Terminated
      Has Results
      • Small Lymphocytic Leukemia (SLL)
      • Chronic Lymphocytic Leukemia (CLL)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 15, 2022

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Rochester (Acalabrutinib, Rituximab)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Small Lymphocytic Lymphoma (SLL)
      • Rochester, New York
        University of Rochester
      Feb 7, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

      Active, not recruiting
      Has Results
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Acalabrutinib (Arm A)
      • Acalabrutinib (Arm B)
      • Bethesda, Maryland
        Research Site
      Jan 3, 2023

      Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

      Recruiting
      • CLL/SLL
      • Jinan, Shandong, China
        Department of Hematology, Shandong Provincial Hospital Affiliate
      Jun 16, 2023

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Small Lymphocytic Leukemia (SLL)
      • Evanston, Illinois
      • +7 more
      Sep 9, 2022

      Chronic Lymphocytic Leukemia Trial (Venetoclax)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • (no location specified)
      Apr 2, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Biospecimen Collection
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Jan 30, 2023

      Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

      Not yet recruiting
      • Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 7, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Dec 5, 2022

      Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Small Lymphocytic Lymphoma
      • (no location specified)
      Jul 19, 2023

      Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

      Active, not recruiting
      • Recurrent Chronic Lymphoid Leukemia
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Dec 19, 2022

      Chronic Lymphocytic Leukemia Trial in Salt Lake City (Nicotinamide, Placebo)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Salt Lake City, Utah
        Huntsman Cancer Institute at University of Utah
      Jan 17, 2023

      Chronic Lymphocytic Leukemia (CLL) Trial in United States (Venetoclax, Obinutuzumab, Acalabrutinib)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Stamford, Connecticut
      • +4 more
      Dec 2, 2022

      Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Zanubrutinib Pill
      • +2 more
      • New York, New York
        Weill Cornell Medicine/NewYork-Presberteryian Hospital
      Dec 6, 2022

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

      Enrolling by invitation
      • Chronic Lymphocytic Leukemia (CLL)
      • Small Lymphocytic Lymphoma (SLL)
      • 5:2 Method (intermittent fasting regimen)
      • 16/8 Method (intermittent fast regimen)
      • Victoria, British Columbia, Canada
        Eleah Stringer
      Feb 2, 2023

      Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in Worldwide (Acalabrutinib, Venetoclax, Obinutuzumab)

      Recruiting
      • Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
      • Tucson, Arizona
      • +40 more
      Dec 20, 2022